A cell-based strategy to assess intrinsic inhibition efficiencies of HIV-1 reverse transcriptase inhibitors. [electronic resource]
- Antimicrobial agents and chemotherapy Feb 2015
- 838-48 p. digital
Publication Type: Journal Article
1098-6596
10.1128/AAC.04163-14 doi
Cell Line Deoxycytidine--analogs & derivatives Emtricitabine HIV Reverse Transcriptase--drug effects Humans Reverse Transcriptase Inhibitors--pharmacology